4.5 Article

Case report: low-titre anti-Yo reactivity in a female patient with psychotic syndrome and frontoparieto-cerebellar atrophy

Journal

BMC PSYCHIATRY
Volume 15, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12888-015-0486-x

Keywords

Anti-Yo reactivity; Low titre; Cerebellum; Atrophy; Paraneoplastic neurological syndrome

Categories

Funding

  1. Bayer Vital GmbH
  2. Biogen Idec
  3. Genzyme
  4. Merck Serono
  5. Novartis
  6. Sanofi-Aventis
  7. Teva
  8. GE
  9. Eli Lilly
  10. Janssen-Cilag
  11. Shire
  12. UCB
  13. GSK
  14. Servier
  15. Janssen
  16. Cyberonics

Ask authors/readers for more resources

Background: Autoimmune and inflammatory mechanisms in psychotic disorders have attracted increasing scientific attention in recent years. In this regard, we performed routine cerebrospinal fluid (CSF) basic diagnostics and CSF/serum analyses for antibodies directed against neuronal intracellular and surface antigens in psychotic patients. In this context, the patient presented in this paper was diagnosed. Case presentation: We present the case of a 20-year-old female patient with a first episode of a drug-induced psychotic syndrome but without neurological deficits. Further investigations showed a reproducible low-titre positive anti-Yo reactivity in the CSF and serum with two independent immunoblot assays. Magnetic resonance imaging showed frontoparietal and cerebellar atrophy. On [F-18] fluorodeoxyglucose positron emission tomography, a mild cerebellar hypometabolism was found. No underlying tumor was detected. Conclusion: Despite the presence of anti-Yo reactivity, the diagnostic criteria for a paraneoplastic neurological syndrome were not fulfilled. Previously published data indicate the possible association between low-titer antibodies against intracellular localized, onconeural antigens, and psychotic disorders. Large prospective studies that investigate the prevalence and clinical significance of antibodies against intracellular onconeural antigens in psychiatry are needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available